Kallikrein 12 Antikörper (AA 151-248)
Kurzübersicht für Kallikrein 12 Antikörper (AA 151-248) (ABIN759026)
Target
Alle Kallikrein 12 (KLK12) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-248
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Cow
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human KLK12
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Kallikrein 12 (KLK12) (Kallikrein-Related Peptidase 12 (KLK12))
-
Andere Bezeichnung
- KLK12
-
Hintergrund
-
Synonyms: Kallikrein12, Kallikrein-12, Kallikrein like protein 5, Kallikrein related peptidase 12, KLK 12, KLK L5, KLK12, KLKL5.
Background: Kallikrein 12, also known as Kallikrein-like5 (KLK-L5), is a trypsin-like serine proteinase. It was discovered by cloning the kallikrein locus on chromosome 19, and was found to be similar to the other kallikrein family genes. It is produced by a number of tissues, including pancreas, salivary gland, breast, prostate, uterus, lung, thymus, thyroid, brain, stomach and colon. Kallikrein 12 message has been reported to be decreased in breast cancer. Different splice variants of kallikrein-12 have been identified, a 254 amino acid form, 248 amino acids form, and a truncated 111 amino acid form.
-
Molekulargewicht
- 27kDa
-
Gen-ID
- 43849
-
Pathways
- Komplementsystem
Target
-